📈 The NYCB story you haven’t heard

The NYCB Thing Gets Worse. Then Better. But Also Worse...

Share on facebook
Share on twitter
Share on linkedin

While everyone else is talking about the Biden-Trump rematch, more drama around the Musk/OpenAI lawsuit, and the State of the Union…

Here are the stories that haven’t been getting much attention.

And if we had to sum it all up in one FinTweet, here it is.

FinTwit Alert

That’s what we’re covering in today’s Weekend Edition of Private Capital Insider.

Let’s dive in,
-Equifund Publishing

P.S. Gold also hit an all time high, miners are still trading a deep discount, and pretty much no one is talking about it. While this is certainly a story we’re tracking as part of the “most predicted recession of all time” narrative, we’ll see where we are after we get through next week.

Also notable news we’ll likely cover next weekend, HR 2799 passed the House and is on its way to the Senate.




The NYCB Thing Gets Worse. Then Better. But Also Worse.

As a reminder, we don’t like to make predictions, nor do we particularly enjoy doom and glooming.

But the slow motion dumpster fire that is NYCB is like the news story that keeps on giving.

For whatever reason, this single regional bank stock manages to connect to a variety of other stories we’ve been following in Private Capital Insider.

For those not in the loop on what’s going on, here’s the short version…

  • Friday, March 1st: NYCB revealed major weaknesses in its ability to monitor risks and replaced Thomas Cangemi as CEO with Flagstar Bank’s Sandro DiNello… and the stock tanks on the open.
  • Wednesday, March 6th: NYCB announces they need to raise funds. After The Wall Street Journal reported on the fundraising effort, the stock plunged more than 40%.

    Steven Mnuchin, along with a rather interesting cast of characters, steps in with a $1bn offer that will dilute the heck out of existing shareholders.

However, the deal doesn’t officially close until Monday, March 11th – which just so happens to be the end of the Federal Reserve’s BTFP (which we covered in the March 2nd Weekend Edition).

Financelot Tweet

To kick things off, let’s start with a bit of a roundup of the mainstream media coverage.

According to Jenny Van Leeuwen Harrington on the March 6th CNBC Halftime Report Investment Committee:

Maybe the regulator shouldn’t have let them acquire [Signature Bank]. No, in retrospect, they should have, because what that did was bump them into that 100 billion asset level. 

And what this arrogant management team did was fail to realize a year ago when they got those assets, that they should have brought in other management who had experience at the big bank level.

If they brought them in a year ago, maybe they would have managed that transition to a larger scale bank better.

The other thing that I want to make a point on is this share price at $1.86 is really upsetting. And part of it is because there’s a lot of predatory players out there.

There’s too many parties right now incentivized to pick off NYCB’s really valuable assets there – Real estate, loans, mortgage servicing business, and there’s all these predators who know how to manipulate the share price very effectively. 

So they may be buying those at fire sale assets. 

We the public shareholders get punished the most. It’s a huge disappointment.

Lots to unpack here, but let’s go in order.

When NYCB acquired Flagstar Bank – and then parts of Signature Bank – this moved NYCB into a “Category IV” Bank.

SIFMA Categories
Source: SIFMA

One of the changes motivated by the Silicon Valley Bank (SVB) collapse in March is the requirement, applicable to all banks with >$100bn assets (i.e., Cat I-IV), to include unrealized gains and losses from their AFS (Available-For-Sale) and HTM (Held-To-Maturity) portfolios in their regulatory capital. 

This was one of the drivers of the SVB collapse, when a deterioration in their HTM portfolio, due to the rising interest rates environment, sparked the panic across depositors about the solvency of the bank.

This acquisition also moved NYCB directly into the crosshairs of the Basel III reserve requirements. If approved, they would force a 19% jump in the required capital for the biggest lenders.

Billions in Excess capital

While there is some growing indication these reserve requirements may change – Federal Reserve Chair Jerome Powell said that U.S. regulators are likely to significantly change their plan to require large lenders to hold more capital…

Until they do, willingly putting your bank into these crosshairs is just… a weird decision.

Second, the management team

Last week, NYCB revealed major weaknesses in its ability to monitor risks, and replaced Thomas Cangemi as CEO with Flagstar Bank’s Alessandro DiNello.

So who are Mnuchin & Friends bringing in to lead NYCB?

Joseph Otting, the former head of the Office of the Comptroller of the Currency – and previous turnaround CEO for Mnuchin when he bought failed mortgage lender IndyMac (which became OneWest) – will become CEO, replacing DiNello, who had taken over less than a week ago.

Joseph Otting
Photographer: Victor J. Blue/Bloomberg

Mnuchin, Otting, Reverence’s Milton Berlinski, and Hudson Bay’s Allen Puwalski will join the NYCB board, which will be reduced to nine members and purged of all legacy NYCB directors.

Third, the entrance of predatory players and potential market manipulation 

While CNBC didn’t go into much detail on this topic, it’s one worth paying attention to.

Here’s one of the strangest parts about this deal. According to Bloomberg,

NYCB is a major lender to owners of apartment buildings subject to tough New York rent laws, limiting the revenue units can generate.

It also financed offices in a region beset by vacancies in the work-from-home era.

Credit-rating firms have slashed the company’s grades to junk, with Moody’s Investors Service predicting the bank may set aside more money for souring loans over the next two years.

NYCB Loans

In 2019, New York renters won sweeping new protections that stopped landlords from raising rents on regulated apartments. Owners were outraged, and their banks found themselves under pressure.

NYCB’s loan portfolio was almost all mortgages, mostly multifamily, and most of those subject to New York rent rules.

Remind me again why exactly anyone wants to acquire a book of loans concentrated in rent-stabilized buildings?

Maybe they don’t.

Let’s take a look at what FinTwit thinks.

JustDario Tweet

Could this be just another round of “pass the hot potato of toxic assets,” while scraping out all the good ones?

Or maybe the better question… What happens when the bank that bailed out a failed bank, fails?

Apparently, if you’re Mnuchin & Friends, you get one of the most incredible trades of all time, when you basically double your money in two hours.

Kobeissi Letter

I wonder if they shorted the stock on the way down too?

Fourth, the highly dilutive terms that have all but wiped out the previous investors.

The new capital infusion has boosted shares since the announcement Wednesday afternoon, with analysts saying it bolsters confidence despite dilution to existing shareholders.

Further details were given Thursday, with NYCB saying the new investors will hold 41.4% of the firm on a converted fully diluted basis.

The firm is issuing nearly 60 million shares of common stock at a price of $2 each, as well as warrants with a term of seven years.

However, this 41.4% number DOES NOT include the warrants, which have a strike price of $2.50 – a 25% premium above what they paid for the common stock.

MaxGoku Tweet
Tweet about dilution

I guess we’ll see what happens next week.

Like this article? Share it with a friend:

Share on facebook
Share on twitter
Share on linkedin

This article is not an Equifund Crowd Funding Portal Inc communication. It is brought to you by Equifund Technologies, LLC.

All information contained in this communication should not be considered investment advice, but education and entertainment only.Investing in private or early stage offerings (such as Reg A, Reg S, Reg D, or Reg CF) involves a high degree of risk. Securities sold through these offerings are not publicly traded and, therefore, are illiquid. Additionally, investors will receive restricted stock that is subject to holding period requirements. Companies seeking capital through these offerings tend to be in earlier stages of development and have not yet been fully tested in the public marketplace. Investing in private or early stage offerings requires a tolerance for high risk, low liquidity, and a long-term commitment. Investors must be able to afford to lose their entire investment. Such investment products are not FDIC insured, may lose value, and have no bank guarantee.

More Articles:

Don't make another private market investment without reading this...

The 5 Mistakes

investors make that crush returns

Download this free report now:

Just enter your name & email to access this report for free.

By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.

More Articles:

Advertisement:

Kleiner Device Labs

Investment Highlights:

  • 1

    Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.

  • 2

    Over 20 patents have been issued to protect the company's technologies.

  • 3

    Just received FDA clearance for their next-generation KG2 spinal fusion technology.

Pre-Investment Agreement

The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO

Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:

    • Received and have reviewed the education materials sent to you.
    • UNDERSTAND; that there are restrictions on your ability to cancel your investment commitment and obtain a return of your investment.
    • KNOW; It may be difficult to resell securities acquired under Regulation Crowdfunding.
    • AGREE; investing in securities offered and sold in reliance on section 4(a)(6) of the Securities Act involves risk. Investors should not invest any funds unless he or she can afford to lose the entire amount of his or her investment. Your investment may not work out, and you must be in a financial condition to bear the loss.
  • Hidden
  • Hidden
  • Hidden
  • Hidden

We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.

Complete Your Registration

By verifying your account you agree with our terms of use, privacy policy and pre-dispute arbitration agreement. Please complete the registration process by clicking the link below:

Verify Your Email

Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.

If you have not received the email in 5 minutes, please click here to have it resent.

Questions? Our customer service team is always here to help – 1-866-338-3004

Enter your email address to get instant access to the video: